3 terminated. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 3 |
| Phase 2 | 2 | Terminated 2 |
Follow Interferon-alpha: new trials by email Literature Review of Interferon-alpha trials Research Report on Interferon-alpha
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer Chemokin Modulatory Regimen (5 MU/m2), Chemokin Modulatory Regimen (10 MU/m2), Chemokin Modulatory Regimen (20 MU/m2) - Colorectal Cancer, Colorectal Carcinoma | Phase 1 / Phase 2 | Terminated | Roswell Park Cancer Institute | 15 | 2012-10-01 | 2023-10-27 |
| Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers allogeneic GM-CSF-secreting breast cancer vaccine, recombinant interferon alfa, cyclophosphamide - Breast Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 / Phase 2 | Terminated | Wiseman Research Initiatives LLC | 24 | 2004-11-01 | 2018-02-05 |
| Safety Study of Low Dose Interleukin 2 (IL-2) Plus PEG-IFN/RBV In Chronic Hepatitis C Virus Genotype I Interleukin 2, Ribavirin, Pegylated Interferon Alpha - Hepatitis C | Phase 1 | Terminated | Weill Medical College of Cornell University | 18 | 2004-03-01 | 2008-03-07 |
Breast Neoplasms (1) · Breast Neoplasms, Male (1) · Colorectal Neoplasms (1) · Hepatitis C (1) · Neoplasm Metastasis (1) · Recurrence (1)
Roswell Park Cancer Institute (1) · Weill Medical College of Cornell University (1) · Wiseman Research Initiatives LLC (1)
United States (3)
Amer H Zureikat, MD (1) · Charles L. Wiseman, MD, FACP (1) · Kendall A Smith, MD (1)
U01AI048224 (1)